Mosapride , 95% , 112885-41-3
CAS NO.:112885-41-3
Empirical Formula: C21H25ClFN3O3
Molecular Weight: 421.89
MDL number: MFCD00867430
Pack Size | Price | Stock | Quantity |
250MG | RMB28.80 | In Stock |
|
1G | RMB65.60 | In Stock |
|
5G | RMB234.40 | In Stock |
|
25g | RMB719.20 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | 151-153°C |
Boiling point: | 549.2±50.0 °C(Predicted) |
Density | 1.272±0.06 g/cm3(Predicted) |
storage temp. | Keep in dark place,Sealed in dry,Room Temperature |
solubility | DMSO (Slightly), Methanol (Slightly) |
form | Solid |
pka | 13.52±0.46(Predicted) |
color | White to Off-White |
CAS DataBase Reference | 112885-41-3(CAS DataBase Reference) |
Description and Uses
Mosapride citrate, a new gastroprokinetic benzamide was introduced in Japan as Gasmotin for the relief of gastrointestinal symptoms in patients with chronic gastritis, gastro-oesophageal reflux, dyspepsia and post-surgery use. Mosapride is synthesized by final amidation between the corresponding benzoic acid, itself obtained in 3 steps from methyl 4-acetamido salicylate, and the appropriate 2-aminomethyl-morpholine. Mosapride is a 5-HT4 partial agonist without notable activity for D2, 5-HT1 , 5-HT2, alpha-1 and alpha-2 receptors. In dogs, mosapride was as potent as cisapride to stimulate antral and duodenal motility. In most of species including man, mosapride undergoes extensive cleavage to a N-debenzylated metabolite which retains partial 5-HT4 activity but has potent 5-HT3 antagonist activity.
gastroprokinetic agent